Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 18 (2), 115-118
- https://doi.org/10.1016/0165-2478(88)90050-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The anti-tumour efficacy of human recombinant interleukin 2Cancer Immunology, Immunotherapy, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.The Journal of Experimental Medicine, 1985
- Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and itsin vitro correction by interleukin 2Journal of Clinical Immunology, 1983
- Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparationsCancer Immunology, Immunotherapy, 1983
- Interleukin-2 augments natural killer cell activityNature, 1981
- Cloned lines of natural killer cellsNature, 1980
- T‐Cell Growth FactorImmunological Reviews, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976